The influence of wear particles in the expression of osteoclastogenesis factors by osteoblasts

Biomaterials

Volumn 25, Issue 27, 2004, Pages 5803-5808

  Pioletti, Dominique P ^a,b   Kottelat, Arlette ^a  

^a EPFL   (Switzerland)

^b Hopital Orthopedique de la Suisse Romande   (Switzerland)

Author keywords

CSF 1; OPG; Orthopedic wear particles; Osteoblast; Osteolysis; RANKL

Indexed keywords

BONE; CELLS; GENES; IMPLANTS (SURGICAL); WEAR OF MATERIALS;

OSTEOCLASTEOGENESIS; WEAR PARTICLES;

BIOMATERIALS;

OSTEOCLAST DIFFERENTIATION FACTOR; OSTEOPROTEGERIN;

ARTICLE; CELL ISOLATION; CONCENTRATION (PARAMETERS); DISEASE ASSOCIATION; GENE EXPRESSION REGULATION; NUCLEOTIDE SEQUENCE; OSTEOBLAST; OSTEOCLAST; OSTEOLYSIS; PARTICLE SIZE; PRIORITY JOURNAL; PROSTHESIS FAILURE; PROSTHESIS LOOSENING; PROSTHESIS MATERIAL; QUANTITATIVE ANALYSIS; SHEAR STRENGTH;

BIOCOMPATIBLE MATERIALS; CARRIER PROTEINS; CELLS, CULTURED; DNA PRIMERS; DRUG DELIVERY SYSTEMS; GENE EXPRESSION REGULATION; GLYCOPROTEINS; HUMANS; MACROPHAGE COLONY-STIMULATING FACTOR; MALE; MEMBRANE GLYCOPROTEINS; MIDDLE AGED; OSTEOBLASTS; OSTEOCLASTS; OSTEOLYSIS; OSTEOPROTEGERIN; PROSTHESIS DESIGN; PROSTHESIS FAILURE; RANK LIGAND; RECEPTOR ACTIVATOR OF NUCLEAR FACTOR-KAPPA B; RECEPTORS, CYTOPLASMIC AND NUCLEAR; RECEPTORS, TUMOR NECROSIS FACTOR; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA; TIME FACTORS;

EID: 2542431059     PISSN: 01429612     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2004.01.053     Document Type: Article

References (45)

1. Friedman R.J., Black J., Galante J.O., Jacobs J.J., Skinner H.B. Current concepts in orthopaedics biomaterials and implant fixation. J Bone Jt Surg. 75-A:1993;1086-1109
2. Glant T.T., Jacobs J.J., Molna'r G., Shanbhag A.S., Valyon M., Galante J.O. Bone-resorption activity of particulate-stimulated macrophages. J Bone Miner Res. 8:1993;1071-1079
3. Goodman S.B., Huie P., Song Y., Lee K., Doshi A., Rushdieh B., Woolson S., Maloney W., Schurman D., Sibley R. Loosening and osteolysis of cemented joint arthroplasties. Clin Orthop Rel Res. 337:1997;149-163
4. Shanbhag A.S., Macaulay W., Stefanovic-Racic M., Rubash H.E. Nitric oxide release by macrophages in response to particulate wear debris. J Biomed Mater Res. 5:1998;497-503
5. Clarke I.C., Campbell P., Kossovsky N. Debris-mediated osteolysis - a cascade phenomenon involving motion, wear, particulates, macrophage induction, and bone lysis. St John K.R. Particulate debris from medical implants: mechanisms of formation and biological consequences, ASTM STP 1144. 1992;7-26 American Society for Testing and Materials, Philadelphia
6. Vermes C., Glant T.T., Hallab N.J., Fritz E.A., Roebuck K.A., Jacobs J.J. The potential role of the osteoblast in the development of periprosthetic osteolysis. review of in vitro osteoblast responses to wear debris, corrosion products, and cytokines and growth factors J Arthroplasty. 16:2001;95-100
7. Zreiqat H., Crotti T.N., Howlett C.R., Capone M., Markovic B., Haynes D.R. Prosthetic particles modify the expression of bone-related proteins by human osteoblastic cells in vitro. Biomaterials. 24:2003;337-346
8. Yao J., Cs-Szabo G., Jacobs J.J., Kuettner K.E., Glant T.T. Suppression of osteoblast function by titanium particles. J Bone Jt Surg. 79-A:1997;107-112
9. Dean D.D., Lohmann C.H., Sylvia V.L., Koster G., Liu Y., Schwartz Z., Boyan B.D. Effect of polymer molecular weight and addition of calcium stearate on response of MG63 osteoblast-like cells to UHMWPE particles. J Orthop Res. 19:2001;179-186
10. Pioletti D.P., Takei H., Kwon S.Y., Wood D., Sung K-.L.P. The cytotoxic effect of titanium particles phagocytosed by osteoblasts. J Biomed Mater Res. 46:1999;399-407
11. Pioletti D.P., Takei H., Lin T., Van Landuyt P., Ma Q.J., Kwon S.Y., Sung K.L.P. The effects of calcium phosphate cement particles on osteoblast functions. Biomaterials. 21:2000;1103-1114
12. Kwon S.Y., Takei H., Pioletti D.P., Lin T., Ma Q.J., Akeson W.H., Wood D.J., Sung K.L.P. Titanium particles inhibit osteoblast adhesion to fibronectin-coated substrates. J Orthop Res. 18:2000;203-211
13. Takei H., Pioletti D.P., Kwon S.Y., Sung K.L. Combined effect of titanium particles and TNF-alpha on the production of IL-6 by osteoblast-like cells. J Biomed Mater Res. 52:2000;382-387
14. Pioletti D.P., Leoni L., Genini D., Takei H., Du P., Corbeil J. Gene expression analysis of osteoblastic cells contacted by orthopedic implant particles. J Biomed Mater Res. 61:2002;408-420
15. Salvati E.A., Betts F., Doty S.B. Particulate metallic debris in cemented total hip arthroplasty. Clin Orthop. 293:1993;160-173
16. Aspenberg P., Herbertsson P. Periprosthetic bone resorption. Particles versus movement. J Bone Jt Surg Br. 78:1996;641-646
17. Bechtold JE, Soballe K, Lewis JL, Gustilo RB. The roles of implant motion and particulate polyethylene debris in the formation of an aggressive periprosthetic membrane. Proceedings of the 41st ORS, 1995. p. 767.
18. Maloney W.J., Smith R.L. Periprosthetic osteolysis in total hip arthroplasty. the role of particulate wear debris J Bone Jt Surg Am. 77-A:1995;1448-1461
19. Boyle W.J., Simonet W.S., Lacey D.L. Osteoclast differentiation and activation. Nature. 423:2003;337-342
20. Kong Y.Y., Yoshida H., Sarosi I., Tan H.L., Timms E., Capparelli C., Morony S., Oliveira-dos-Santos A.J., Van G., Itie A., Khoo W., Wakeham A., Dunstan C.R., Lacey D.L., Mak T.W., Boyle W.J., Penninger J.M. OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis. Nature. 397:1999;315-323
21. Simonet W.S., Lacey D.L., Dunstan C.R., Kelley M., Chang M.S., Luthy R., Nguyen H.Q., Wooden S., Bennett L., Boone T., Shimamoto G., DeRose M., Elliott R., Colombero A., Tan H.L., Trail G., Sullivan J., Davy E., Bucay N., Renshaw-Gegg L., Hughes T.M., Hill D., Pattison W., Campbell P., Boyle W.J., et al. Osteoprotegerin. a novel secreted protein involved in the regulation of bone density Cell. 89:1997;309-319
22. Fuller K., Owens J.M., Jagger C.J., Wilson A., Moss R., Chambers T.J. Macrophage colony-stimulating factor stimulates survival and chemotactic behavior in isolated osteoclasts. J Exp Med. 178:1993;1733-1744
23. Lacey D.L., Timms E., Tan H.L., Kelley M.J., Dunstan C.R., Burgess T., Elliott R., Colombero A., Elliott G., Scully S., Hsu H., Sullivan J., Hawkins N., Davy E., Capparelli C., Eli A., Qian Y.X., Kaufman S., Sarosi I., Shalhoub V., Senaldi G., Guo J., Delaney J., Boyle W.J. Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation. Cell. 93:1998;165-176
24. Clohisy J.C., Frazier E., Hirayama T., Abu-Amer Y. RANKL is an essential cytokine mediator of polymethylmethacrylate particle-induced osteoclastogenesis. J Orthop Res. 21:2003;202-212
25. Kim K.J., Kotake S., Udagawa N., Ida H., Ishii M., Takei I., Kubo T., Takagi M. Osteoprotegerin inhibits in vitro mouse osteoclast formation induced by joint fluid from failed total hip arthroplasty. J Biomed Mater Res. 58:2001;393-400
26. Crotti T.N., Smith M.D., Findlay D.M., Zreiqat H., Ahern M.J., Weedon H., Hatzinikolous G., Capone M., Holding C., Haynes D.R. Factors regulating osteoclast formation in human tissues adjacent to peri-implant bone loss. expression of receptor activator NFkappaB, RANK ligand and osteoprotegerin Biomaterials. 25:2004;565-573
27. Lohmann C.H., Schwartz Z., Koster G., Jahn U., Buchhorn G.H., MacDougall M.J., Casasola D., Liu Y., Sylvia V.L., Dean D.D., Boyan B.D. Phagocytosis of wear debris by osteoblasts affects differentiation and local factor production in a manner dependent on particle composition. Biomaterials. 21:2000;551-561
28. Beresford J.N., Gallagher J.A., Poser J.W., Russell R.G. Production of osteocalcin by human bone cells in vitro. Effects of 1, 25(OH)2D3, 24, 25(OH)2D3, parathyroid hormone, and glucocorticoids. Metab Bone Dis Relat Res. 5:1984;229-234
29. Puleo D.A., Holleran L.A., Doremus R.H., Bizios R. Osteoblast responses to orthopedic implant materials in vitro. J Biomed Mater Res. 25:1991;711-723
30. Stringa E., Filanti C., Giunciuglio D., Albini A., Manduca P. Osteoblastic cells from rat long bone. I. Characterization of their differentiation in culture. Bone. 16:1995;663-670
31. Hofbauer L.C., Khosla S., Dunstan C.R., Lacey D.L., Boyle W.J., Riggs B.L. The roles of osteoprotegerin and osteoprotegerin ligand in the paracrine regulation of bone resorption. J Bone Miner Res. 15:2000;2-12
32. Vandesompele J., De Preter K., Pattyn F., Poppe B., Van Roy N., De Paepe A., Speleman F. Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biol. 3:2002;0034.1-0034.11
33. Lam J., Takeshita S., Barker J.E., Kanagawa O., Ross F.P., Teitelbaum S.L. TNF-alpha induces osteoclastogenesis by direct stimulation of macrophages exposed to permissive levels of RANK ligand. J Clin Invest. 106:2000;1481-1488
34. Takagi M. Neutral proteinases and their inhibitors in the loosening of total hip prostheses. Acta Orthop Scand. 67:1996;1-29
35. Nakano M., Tsuboi T., Kato M., Kurita K., Togari A. Inhibitory effect of titanium particles on osteoclast formation generated by treatment of mouse bone marrow cells with PGE2. Oral Dis. 9:2003;77-83
36. Gonzalez O., Smith R.L., Goodman S.B. Effect of size, concentration, surface area, and volume of polymethylmethacrylate particles on human macrophages in vitro. J Biomed Mater Res. 30:1996;463-473
37. Allen M.J., Myer B.J., Millett P.J., Rushton N. The effects of particulate cobalt, chromium and cobalt-chromium alloy on human osteoblast-like cells in vitro. J Bone Jt Surg. 79-B:1997;475-482
38. Gonzales J.B., Purdon M.A., Horowitz S.M. In vitro studies on the role of titanium in aseptic loosening. Clin Orthop. 330:1996;244-250
39. Horowitz S.M., Gonzales J.B. Inflammatory response to implant particulates in a macrophage/osteoblast coculture model. Calc Tissue Int. 59:1996;392-396
40. Martinez M.E., Medina S., del Campo M.T., Garcia J.A., Rodrigo A., Munuera L. Effect of polyethylene particles on human osteoblastic cell growth. Biomaterials. 19:1998;183-187
41. Zambonin G., Colucci S., Cantatore F., Grano M. Response of human osteoblasts to polymethylmetacrylate In vitro. Calcif Tissue Int. 62:1998;362-365
42. Childs L.M., Paschalis E.P., Xing L., Dougall W.C., Anderson D., Boskey A.L., Puzas J.E., Rosier R.N., O'Keefe R.J., Boyce B.F., Schwarz E.M. In vivo RANK signaling blockade using the receptor activator of NF- kappaB. Fc effectively prevents and ameliorates wear debris-induced osteolysis via osteoclast depletion without inhibiting osteogenesis J Bone Miner Res. 17:2002;192-199
43. Goater J.J., O'Keefe R.J., Rosier R.N., Puzas J.E., Schwarz E.M. Efficacy of ex vivo OPG gene therapy in preventing wear debris induced osteolysis. J Orthop Res. 20:2002;169-173
44. Yang S.Y., Mayton L., Wu B., Goater J.J., Schwarz E.M., Wooley P.H. Adeno-associated virus-mediated osteoprotegerin gene transfer protects against particulate polyethylene-induced osteolysis in a murine model. Arthritis Rheum. 46:2002;2514-2523
45. Peter B., Pioletti D.P., Terrier A., Rakotomanana L. Orthopedic implant used as a drug delivery system. a numerical study Comput Methods Biomech Biomed Eng. 4:2001;505-513